Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This statistic discloses the sales value of medication of the French pharmaceutical group Ipsen in 2019, in million euros. The sales value of Somatuline® reached 1.03 billion euros, which represented more than one quarter of the group's revenue in 2019. The sale of Smecta® was worth 125.6 million euros.
Sales of the French pharmaceutical group Ipsen in 2019, by medication (in million euros)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Commercial expenses of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
- Premium Statistic Global revenue of the Ipsen group 2014-2019
- Premium Statistic Global revenue in specialty medicine of the Ipsen group 2014-2019
About the region
10
- Basic Statistic Ipsen group sales 2019, by therapeutic area
- Premium Statistic Research and development expenditure of the Ipsen group 2014-2019
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Premium Statistic Top global companies by orphan drug revenues 2023
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Basic Statistic Merck & Co. number of employees 2008-2023
- Premium Statistic Annual sales percent change top pharmaceutical companies globally 2021-2022
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
Selected statistics
5
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Top pharmaceutical companies in Sweden by sales 2022
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Premium Statistic Revenue value from biotechnology companies in Germany 2008-2022
- Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2022
- Premium Statistic Pharma market value in Argentina 2008-2021
- Basic Statistic Annual revenues of BRICS country pharmaceutical industry 2013-2015
- Premium Statistic Grifols immunoglobulin monthly market share in the U.S. 2016-2017
Related statistics
10
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Basic Statistic Total revenue of the French drug market worldwide 2010-2018
- Basic Statistic Trust levels towards hospitals in selected countries worldwide 2023
- Premium Statistic Number of companies in the pharmaceutical industry in France 1970-2018
- Basic Statistic Opioid-related inpatient stays under Medicare U.S. 2010 and 2015, by state
- Premium Statistic Number of employees of Guerbet by in France 2017, by activity site
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Premium Statistic Boiron laboratories' European turnover in 2022, by country
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
Further related statistics
10
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Celgene's revenue and net income 2006-2018
- GSK's operating profit by division 2006-2021
- M&A capacities - changes for the global pharma industry 2008-2015
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Celgene's revenue and net income 2006-2018
- GSK's operating profit by division 2006-2021
- M&A capacities - changes for the global pharma industry 2008-2015
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
Ipsen. (February 13, 2020). Sales of the French pharmaceutical group Ipsen in 2019, by medication (in million euros) [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/1072752/ipsen-annual-sales-medication-french-company/
Ipsen. "Sales of the French pharmaceutical group Ipsen in 2019, by medication (in million euros)." Chart. February 13, 2020. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/1072752/ipsen-annual-sales-medication-french-company/
Ipsen. (2020). Sales of the French pharmaceutical group Ipsen in 2019, by medication (in million euros). Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/1072752/ipsen-annual-sales-medication-french-company/
Ipsen. "Sales of The French Pharmaceutical Group Ipsen in 2019, by Medication (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1072752/ipsen-annual-sales-medication-french-company/
Ipsen, Sales of the French pharmaceutical group Ipsen in 2019, by medication (in million euros) Statista, https://www.statista.com/statistics/1072752/ipsen-annual-sales-medication-french-company/ (last visited May 21, 2024)
Sales of the French pharmaceutical group Ipsen in 2019, by medication (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1072752/ipsen-annual-sales-medication-french-company/